Korean J Intern Med.  2021 Sep;36(5):1115-1125. 10.3904/kjim.2020.551.

The Korean Hypertension Cohort study: design and baseline characteristics

Affiliations
  • 1Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea
  • 2College of Pharmacy, Seoul National University, Seoul, Korea
  • 3National Evidence-based Healthcare Collaborating Agency (NECA), Seoul, Korea
  • 4Department of Internal Medicine, Seoul National University Bundang Hospital, Sungnam, Korea
  • 5Department of Internal Medicine, Kyungpook National University Hospital, Daegu, Korea
  • 6Division of Cardiology, Department of Internal Medicine, Chungbuk National University Hospital, Cheongju, Korea
  • 7Department of Cardiovascular Medicine, Chonnam National University Hospital, Gwangju, Korea
  • 8Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea
  • 9Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea

Abstract

Background/Aims
Hypertension (HT) has a significant impact on public health and medical expenses. However, HT is a chronic disease that requires the long-term follow-up of a large number of patients.
Methods
The Korean Hypertension Cohort (KHC) study aimed to develop a model for calculating cardiovascular risk in HT patients by linking and utilizing the detailed clinical and longitudinal data from hospitals and the national health insurance claim database, respectively. This cohort had a planned sample size of over 11,000 HT patients and 100,000 non-HT controls. Eligible patients were hypertensive patients, who were presenting for the first time and were diagnosed with HT as a main disease from 2006 to 2011. Long-term survival data over a period of approximately 9 years were obtained from the national health insurance claim and national health examination data.
Results
This cohort enrolled 11,083 patients with HT. The mean age was 58.87 ± 11.5 years, 50.5% were male, and 31.4% were never-treated HT. Of the enrolled patients, 32.9% and 37.7% belonged to the high and moderate cardiovascular risk groups, respectively. Initial blood pressures were 149.4 ± 18.5/88.5 ± 12.5 mmHg. During the 2 years hospital data follow-up period, blood pressures lowered to 130.8 ± 14.1/78.0 ± 9.7 mmHg with 1.9 ± 1.0 tablet doses of antihypertensive medication. Cardiovascular events occurred in 7.5% of the overall patients; 8.5%, 8.8%, and 4.7% in the high, moderate, and low risk patients, respectively.
Conclusions
The KHC study has provided important information on the long-term outcomes of HT patients according to the blood pressure, comorbid diseases, medication, and adherence, as well as health behaviors and health resource use.

Keyword

Hypertension; Cohort
Full Text Links
  • KJIM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr